https://www.pharmamanufacturing.com/industry-news/news/55376057/bristol-myers-squibb-licenses-lonza-adc-platform-for-undisclosed-oncology-targetPharma Manufacturingen2026-05-07T14:52:44.000ZBristol Myers Squibb licenses Lonza ADC platform for undisclosed oncology targethttps://www.pharmamanufacturing.com/industry-news/news/55376054/made-scientific-partners-with-roosterbio-on-scalable-msc-manufacturingPharma Manufacturingen2026-05-07T14:19:58.000ZMade Scientific partners with RoosterBio on scalable MSC manufacturinghttps://www.pharmamanufacturing.com/industry-news/news/55375831/epicrispr-taps-forge-for-aav-manufacturing-of-gene-therapy-candidatePharma Manufacturingen2026-05-06T15:32:37.000ZEpicrispr taps Forge for AAV manufacturing of gene therapy candidatehttps://www.pharmamanufacturing.com/industry-news/news/55375827/cellular-origins-and-immatics-team-on-cell-therapy-automationPharma Manufacturingen2026-05-06T15:15:13.000ZCellular Origins and Immatics team on cell therapy automationhttps://www.pharmamanufacturing.com/industry-news/news/55375522/sanofi-invests-294m-to-expand-ai-center-of-excellence-in-torontoPharma Manufacturingen2026-05-05T16:36:07.000ZSanofi invests $294M to expand AI Center of Excellence in Torontohttps://www.pharmamanufacturing.com/industry-news/news/55375494/thermo-fisher-launches-platform-for-scalable-cell-therapy-manufacturingPharma Manufacturingen2026-05-05T15:49:24.000ZThermo Fisher launches platform for scalable cell therapy manufacturing